The company anticipates organic revenue growth in the range of 3% to 5% for fiscal 2026. Multiomics is expected to deliver low single-digit growth, while Sample Management Solutions is expected to ...
Doradla guided fourth quarter revenues to be "in the range of $105 million to $107 million" and non-GAAP EBITDA "in the range of $13 million to $14 million." Full year revenue outlook is expected to ...
Management reiterated it is not updating its full-year view after Q1, with Voskuil stating, "we're not changing the guide," and adding the company intends to reassess later: "We'll be in a better spot ...